James C. Borel has reported a transaction involving 1,776 shares of Neogen Corp stock. The transaction took place on October 29, 2026, and was filed with the SEC on October 30, 2026. This activity highlights ongoing engagement with Neogen Corp, a key player in the life sciences sector.
Neogen Corp, identified by CIK 0000711377, operates under the SIC classification for in vitro and in vivo diagnostic substances. The company is incorporated in Michigan and has its fiscal year ending on May 31. Neogen is known for its contributions to health and safety, focusing on diagnostic solutions.
According to the filing, Borel acquired 1,776 shares of Neogen's common stock at a price of $12.21 per share. Following this transaction, Borel now owns a total of 106,737 shares of the company. The filing notes that these shares were acquired through the vesting of restricted stock units (RSUs), which were settled for an equal number of shares.
This transaction may affect Borel's standing within Neogen Corp, as he is identified as a director of the company. His continued investment may signal confidence in Neogen's future prospects.
Details regarding future actions or additional filings were not available in the SEC filing.
Transaction Details
The transaction reported by Borel involved the acquisition of restricted stock units (RSUs) that vested on the same day, October 29, 2026. Each RSU represents the economic equivalent of one share of Neogen Corp's common stock. This means that Borel's acquisition of 1,776 shares was a direct result of the vesting of these RSUs, which were settled for an equal number of shares.
"On October 29, 2026, these RSUs vested and were settled for an equal number of shares of common stock."
According to the filing, the transaction was categorized under the code 'M', indicating that it was a transaction involving the acquisition of shares. The shares were acquired at a price of $12.21 per share, reflecting the conversion price of the RSUs. Following the transaction, Borel's total ownership of Neogen Corp shares stands at 106,737.
Ownership Structure
Borel's ownership is classified as direct, meaning he has direct control over the shares he owns. The filing does not indicate any additional ownership interests or relationships that may exist beyond this direct ownership. Furthermore, there is no mention of any future plans or intentions regarding additional transactions or share dispositions.
Additionally, the filing provides the business address for Neogen Corp, which is located at 620 Lesher Place, Lansing, MI 48912, the same address listed for Borel, suggesting a close operational connection.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






